跳至主要内容
临床试验/IRCT138805192326N1
IRCT138805192326N1已完成未知

Assessment of subconjunctival bevacizumab effect on the postoperative healing course and recurrence of excised primary pterygium in patients referring to ophthalmology clinics

Vice-chancellery of Research Affairs of Shiraz University of Medical Sciences0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • the patients with primary pterygium referring to the ophthalmology clinics, affiliated to Shiraz University of Medical Sciences, that want pterygium removal. Exclusion criteria: glaucoma, regurgitation from lacrimal punctum (any indication of nasolacrimal obstruction), patients that seems not coming for follow-up exams during study, not treated diabetic patients, autoimmune diseases, pregnant patients, patients with ocular surface diseases or infections, two headed pterygium, previous limbal surgery, previous pterygial surgery.

排除标准

  • 未提供

研究者

发起方
Vice-chancellery of Research Affairs of Shiraz University of Medical Sciences

相似试验

Assessment of subconjunctival bevacizumab effect on... | 临床试验